WCN2015logo

FacebookTwitterLinkedin
post event banner

insidebannerwcn2015

Abstracts

 

CLICK HERE to view all accepted abstracts.

The WCN thanks Sanofi Renal for its support. 

 

CLICK HERE to view poster presentations.

The WCN thanks F. Hoffmann-La Roche Ltd for its support.

 

 You can search by:

  • Free text (Above left in black bar)
  • Categories (Alphabetical order)
  • Sessions (Alphabetical order)
  • Author names (Alphabetical order)
  • Title (Alphabetical order)
  • Abstract numbers

 

Abstract submissions are closed.

The organizers of WCN 2015 invited the nephrology community to submit abstracts to WCN 2015. Submissions for poster presentations (moderated poster sessions) as well as oral presentations in the Congress Scientific Symposia could be made. WCN Congress registration is required for both presentation formats upon acceptance notification. Opportunities for allied health professionals submitters also existed for additional presentations during the pre-congress Allied Health Professional Symposium to be held on Friday March 13, 2015.

A call for Late Breaking Abstracts occured from October 28, 2014 and closed on December 14, 2014. Click here for more details.

 

SUBMISSION OF ABSTRACTS
Abstracts should concern all aspects of nephrology, the treatment of renal disease or the scientific background to the study of the kidney.

 

MAILING OR FAXING YOUR ABSTRACT
A hard copy of the submitted abstract is NOT required for submission. All submissions must be made through the ISN WCN 2015 website.

  

CONFIRMATION
You will receive an email within two (2) business days of submitting your abstract. If you submit on the date of the deadline and do not receive confirmation within 48 hours, please contact Shira Strachova at ISN via sstrachova@theisn.org.

 

NOTIFICATION
The Presenting Author of each abstract accepted for publication/presentation at the Congress will be notified by November 28, 2014. The abstract submitters of accepted abstracts are entitled to register at the discounted registration fees provided they register by the early bird deadline ( December 14, 2014).

 If the Presenting Author is unable to present the abstract, another Co-Author can take his/her place. A letter from the Presenting Author informing about the change is requested and must be sent to the WCN 2015 Congress Office by February 13, 2015.

 

WITHDRAWAL/CHANGES
Submitted abstracts CANNOT be withdrawn or changed. No exceptions will be made.

 

ORIGINAL ABSTRACTS
Submitted abstracts must describe unpublished work which is not already in press and which is not awaiting possible acceptance by any other society that publishes its proceedings.

 

ABSTRACT PUBLICATION
Accepted abstracts will be published electronically in a searchable database on the WCN 2015 and ISN websites. No printed Abstract Book will be produced.

 

COPYRIGHT
By submitting this abstract, the author assigns copyright to the ISN.

 

ORGAN TRAFFICKING AND TOURISM ETHICS COMPLIANCE
ISN supports the need to stop practices and policies of organ trafficking and tourism. Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the below policy documents. To be eligible to submit an abstract for the ISN WCN 2015, submitters must disclose that the author(s)/ scientist(s) have not violated any aspect of the following:

The Declaration of Istanbul on Organ Trafficking and Transplant Tourism Lancet. 2008 Jul 5;372 (9632):5-6.

For Live Kidney Donation - The Consensus Statement of the Amsterdam Forum (Transplantation 79(6): S53-S66, 2005).

For Live Donation of Extrarenal Organs - The Consensus Statement of the Vancouver Forum (Transplantation 81(4): 1373-1385, 2006).

For Studies of Xenotransplantation - The International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003).

For research involving human subjects - The Helsinki Declaration of The World Medical Association.

The Ethical Statements of the Transplantation Society, TTS Ethics Policy.

The TTS Ethics China.

The Ethical Statements of the International Xenotransplantation Association.

 

SUBMISSION DEADLINE
The abstract submission deadline was extended to November 3, 2014 (23.59 CET). Abstracts received after the deadline were not considered.

 

CATEGORIES AND TOPICS
Abstracts will be considered for Moderated Poster Presentation or Oral Presentation (only limited slots are available for oral presentation during WCN 2015).

Abstract submitters may submit papers in one (1) of the following categories:

 

Infectious and non-infectious risk factors

  • Diabetic nephropathy – Experimental models
  • Diabetes mellitus (Clinical)
  • Hypertension - Clinical and experimental models, renal haemodynamics and vascular physiology
  • Infection and renal disease
  • HIV - Nephropathy

 

Acute Kidney Injury (AKI)

  • Acute renal failure – Experimental models
  • Clinical studies including toxic nephropathy
  • Biomarkers for acute kidney injury
  • Acute renal failure - Clinical

 

Translational and clinical nephrology

  • Cell signaling, cell growth control, hormones and cytokines
  • Renal development and cystic disease (Aetiology)
  • Inherited diseases and molecular genetics
  • GN – Experimental models
  • Renal pathology, experimental pathology, including immune and inflammatory mechanisms
  • Other renal disease - Experimental models
  • Primary glomerular disease (Clinical)
  • Secondary glomerular disease
  • Vasculitides (Clinical)
  • Tubulointerstitial renal disease, stones, urinary infection
  • Paediatric nephrology
  • Pregnancy and CKD
  • Supportive care, including end-of-life issues

 

CKD and its consequences

  • Acid base and electrolyte abnormalities, protein and cellular physiology
  • Cardiovascular complications of CKD 3-5
  • Chronic kidney disease diagnosis, classification and progression
  • Epidemiology, outcomes and health service research in CKD
  • Bone and mineral metabolism (CKD 3-5)
  • Anaemia (CKD 3-5)
  • Nutrition (CKD 3-5)
  • Infection (CKD 3-5)

 

Dialysis and transplantation

  • Extracorporeal dialysis: Techniques and adequacy
  • Peritoneal dialysis
  • Vascular access in dialysis
  • Haemodialysis
  • Complications of dialysis
  • Epidemiology, outcomes and health services research in dialysis
  • Transplantation: Basic science and immune tolerance
  • Clinical studies in renal transplantation
  • Cardiovascular complications of CKD 5D
  • Bone and mineral metabolism (CKD 5D)
  • Anaemia (CKD 5D)
  • Nutrition (CKD 5D)
  • Infection (CKD 5D)

 

FURTHER INSTRUCTIONS FOR COMPLETING YOUR ONLINE ABSTRACT SUBMISSION
Please check your abstract carefully for typographical errors, misspellings, poor hyphenation, etc. They will be glaringly apparent in the published abstract.

You are allowed to use 3400 characters. This count includes characters and spaces in the following: Abstract Title, Abstract Body, Authors/Institutions, Table, and Figures.

Click the buttons on the left side of the abstract submissions screen and complete each section by following the instructions within each section. Please note, the sections of the menu which are followed by an asterisk (*) must be filled out in order for your abstract to be submitted successfully. The required sections are:

  • Authors and Institutions
  • Correspondence Information
  • Category
  • Questionnaire
  • Transparency Declaration Ethics Statement
  • Keywords
  • Abstract Title
  • Abstract Body
  • Submit Abstract

 

CATEGORY
Choose only one (1) Category.

 

TITLE
Type in CAPITAL LETTERS. Lowercase may be used for abbreviations only, for example, mRNA. If you use abbreviations, please spell them out.

 

AUTHORS
Type in lower case.

 

PRESENTING AUTHOR
The Presenting Author must also be the Contact Author and all WCN 2015 abstract follow-up communications will be sent to the Presenting Author.

 

AFFILIATION
Type in lower case. Type name and institution, city and country only.

 

BODY OF ABSTRACT
State the purpose of the study, describe the method, summarize the results presenting sufficient details to support the conclusions, and give the conclusions reached (it is not acceptable to state "The results will be discussed"). Divide the text into no more than 3-4 paragraphs. Use numerals for numbers and only very well-known abbreviations e.g. ml, Osm, GFR. If you must use other abbreviations, please explain them the first time they appear. Limit the use of symbols (i.e. use M or F to indicate Male and Female instead of the symbol font). Do not identify yourself or your institution in the text.

 

TABLES AND GRAPHS
Simple tables and graphs may be included if they fit within the size constraints of the online program.